Serum-borne lipids amplify TLR-activated inflammatory responses.

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Toll-like receptors (TLRs) are crucial for innate immunity, recognizing pathogen-associated molecular patterns (PAMPs).
• Circulating and cell-associated proteins modulate TLR signaling and inflammatory responses.
• The role of host lipids in TLR-mediated immunity requires further elucidation.

Purpose of the Study:

• To investigate the role of serum and serum-borne lipids, specifically lysophosphatidylcholine (LPC), in amplifying TLR-induced inflammatory responses.
• To identify the molecular mechanisms, including G protein-coupled receptor (GPCR) signaling, involved in lipid-mediated augmentation of TLR responses.

Main Methods:

• In vitro stimulation of intestinal epithelial cells and mononuclear phagocytes with microbial TLR ligands, serum, and LPC.
• Pharmacological inhibition of GPCR signaling (suramin, pertussis toxin [PT]) and JNK-MAPK pathway.
• Genetic knockdown of the LPC-responsive GPCR, G2A.
• In vivo studies involving administration of PT and anti-G2A antibody to assess TLR2-activated cytokine secretion.

Main Results:

• Serum and LPC significantly amplify inflammatory responses in TLR-primed cells.
• Inhibition of GPCR signaling (suramin, PT) or G2A knockdown abrogates serum/LPC-mediated augmentation of TLR responses.
• In vivo administration of PT or anti-G2A antibody reduces TLR2-induced cytokine secretion.

Conclusions:

• Host lipids, including LPC, act as potent amplifiers of TLR-initiated innate immune and inflammatory responses.
• GPCR signaling, particularly involving G2A, is a key mediator of this lipid-driven amplification pathway.
• This discovery uncovers a novel mechanism for enhancing innate immunity and inflammation through host lipid-TLR crosstalk.